Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,446 total articles
LB Pharmaceuticals Inc, a late-stage biopharmaceutical company focused on neuropsychiatric diseases, announced that its executives will present at the Jefferies Global Healthcare Conference and the H.C. Wainwright Annual Neuro Perspectives Conference in June 2026. The company is advancing its lead product candidate, LB-102, a potential first benzam…
Peloton Interactive, Inc. announced that CEO Peter Stern will participate in a fireside chat at the upcoming Baird 2026 Global Consumer, Technology & Services Conference. The event will be webcast live and available for replay via the company's investor relations website.
Equillium, Inc., a biotech company focused on therapies for autoimmune and inflammatory disorders, announced its management team will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference, providing an opportunity to engage with investors.
Ambarella and Hanwha have signed a landmark long-term agreement worth over $800 million to collaborate on edge AI SoC technology across Hanwha's portfolio including video security, robotics, industrial automation, and life sciences. This multi-generational partnership aims to accelerate innovation and deployment of AI-enabled products leveraging Am…
El Pollo Loco Holdings, Inc. has authorized a $40 million share repurchase program, representing approximately 9% of its market capitalization. The buyback reflects confidence in strong cash flow and a solid balance sheet with less than 1x leverage, supporting the company's plans to accelerate unit and EBITDA growth while balancing organic investme…
rYojbaba Co., Ltd., a Japan-based company specializing in labor consulting and health services, rang the Nasdaq Opening Bell on May 26, 2026, marking its listing on the U.S. stock exchange. The company emphasizes its mission to fight poverty through combining professional expertise in legal, labor, and healthcare services, supporting communities an…
CG Oncology, Inc. announced that its Chairman, President & CEO, Arthur Kuan, will participate in presentations at the Jefferies Global Healthcare Conference and the Goldman Sachs 47th Annual Global Healthcare Conference in early June 2026. The company focuses on developing innovative immunotherapies for bladder cancer and will webcast the sessions …
Nasdaq, a leading technology platform in financial markets, announced that its executives including Chair & CEO Adena Friedman and President Tal Cohen will present at multiple investor conferences in June 2026. Presentations will be webcast for public access.
Ambarella, Inc. announced its first quarter fiscal year 2027 financial results, showing a 16.9% year-over-year revenue increase to $100.4 million. The company reported improved non-GAAP net profit of $5.0 million and a positive outlook for the next quarter revenue between $105 million and $111 million. CEO highlighted record automotive revenue driv…
Viasat, Inc., a global satellite communications company, announced its financial results for the fourth quarter and fiscal year 2026. The company provides a live webcast and conference call to discuss the financial details. The release highlights Viasat's recent strategic acquisition of Inmarsat, reinforcing its position in the global communication…
Runway Growth Finance Corp. announced the pricing of an underwritten public offering of $50 million aggregate principal amount of 7.00% notes due December 1, 2029. Net proceeds of approximately $48.4 million will be used primarily to repay outstanding indebtedness under its Credit Facility as well as for general corporate purposes. The notes will p…
Wealthfront Corporation announced that its top executives, including CEO David Fortunato and CFO Alan Imberman, will present at the RBC Capital Markets Global Financial Technology Conference and the Morgan Stanley US Financials Conference in June 2026. The presentations will be available via live webcast on the company's investor relations website.
Hudson Technologies announced a bridge contract extension with the U.S. Defense Logistics Agency (DLA), enabling continuation of refrigerant supply and services while the DLA reviews a bid protest related to the recent contract award. The extension maintains service continuity through November 2026, with potential additional three-month extensions.…
Kailera Therapeutics, a clinical-stage biotech focused on obesity care, announced its CEO will present at the 2026 Jefferies Global Healthcare Conference. The company highlighted its diversified pipeline of GLP-1-based obesity treatments, including its lead product ribupatide injection in Phase 3 trials, and its efforts to develop oral and injectab…
Netcapital Inc. has acquired the NetNudge AI Agent Platform assets from Codesharp Corporation to expand its AI-powered solutions in private capital markets. The acquisition supports Netcapital's strategy to leverage its regulatory infrastructure and deliver scalable AI-enabled tools and services, including operational intelligence and workflow auto…
Holley Performance Brands announced their participation in the William Blair Growth Stock Conference on June 3, 2026, where senior management will present and hold investor meetings. The company is known for its portfolio of high-performance automotive aftermarket brands.
Editas Medicine, a gene editing company focused on developing transformative in vivo medicines, updated the timing of its presentation at the 2026 Jefferies Global Healthcare Conference to 2:00 p.m. ET on June 4, 2026. The event will be webcast and archived on the company's website.
Opus Genetics, a clinical-stage biopharmaceutical company focused on gene therapies for inherited retinal diseases, granted 698,000 stock options to ten newly hired non-executive employees as inducements to employment, in compliance with Nasdaq listing rules. These options vest over four years with an exercise price equal to the fair market value a…
HealthEquity, Inc., the largest independent HSA custodian in the US, announced a 29% increase in net income to $69.4 million for Q1 ended April 30, 2026, alongside a 7% revenue growth to $354.6 million. The company expanded its share repurchase program by $1 billion and raised its fiscal 2027 financial outlook, projecting revenues between $1.41 bil…
Asure Software expands its strategic partnership with FRPG Restaurant Rewards, a large GPO serving independent restaurants, to enhance distribution and offer comprehensive cloud-based HR, payroll, and workforce management solutions tailored for the independent restaurant sector. This move aims to help independent restaurants manage labor costs, com…
New Era Energy & Digital, Inc. announced a pending settlement agreement that would result in the dismissal of the company's claims in a lawsuit filed by the State of New Mexico. The agreement includes a $1 million payment to the bankruptcy trustee and explicitly denies liability. The company remains focused on developing its large-scale AI data cen…
Emergent BioSolutions Inc. has secured a $64.5 million contract modification from the U.S. Department of Health and Human Services to provide Botulism Antitoxin Heptavalent (BAT®) as part of its ongoing biodefense supply efforts. The contract supports treatment against botulinum neurotoxin exposure and highlights Emergent's role in national health …
Apogee Therapeutics announced that its management will participate in upcoming Jefferies and Goldman Sachs global healthcare conferences in June 2026, highlighting its clinical-stage biotech developments in immunology and inflammation disease treatments. The company focuses on novel biologics targeting atopic dermatitis, asthma, eosinophilic esopha…
Outlook Therapeutics, a biopharmaceutical company developing ophthalmic formulations for retinal diseases, has priced a $5.0 million at-the-market registered direct offering of 8.5 million shares to its largest shareholder, GMS Ventures and Investments. The proceeds will be used for working capital and general corporate purposes. Additionally, the …
Regeneron Pharmaceuticals announced that the World Health Organization's Therapeutics Advisory Group has recommended prioritizing evaluation of maftivimab, a potent antibody component of its Ebola treatment Inmazeb, for investigational use against the current Bundibugyo ebolavirus outbreak in the Democratic Republic of Congo and Uganda. Inmazeb is …
